Home
Clinical Trials
Partnerships
Contact Us
News
Careers
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Disease
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Our Science and Technology
Investors
Press Releases
Events and Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Diseases
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Our Science and Technology
News and Resources
News
Posters
Videos
Publications
Investors
Press Releases
Company Information
Corporate Governance
Events and Presentations
SEC Filings
Stock Information
Careers
Partnerships
Contact Us
Search our website
Video
VBI-1901: SNO Phase 2a Data & Clinical Update
November 19th, 2020
Sci-B-Vac® Late-Breaker Oral Presentation at EASL 2020
August 31st, 2020
Preclinical Coronavirus Program Data Webcast
August 26th, 2020
VBI-1901: AACR Data and Clinical Update
June 22nd, 2020
VBI-1901: AACR 2020 Webcast
June 22nd, 2020
First- and Second-Generation Hepatitis B Vaccines
October 27th, 2016
VBI-1901 Therapeutic Cancer Vaccine Design
October 26th, 2016
Preclinical Studies in Glioblastoma (“GBM”)
October 25th, 2016
Next Steps in the Development of Sci-B-Vac™
October 25th, 2016
About Medulloblastoma (“MB”)
October 25th, 2016
About Glioblastoma (“GBM”)
October 25th, 2016
LPV™ Thermostability Platform
October 25th, 2016
About Hepatitis B
October 15th, 2016
Cytomegalovirus (“CMV”) Vaccine Candidate
August 15th, 2014
Enveloped Virus-Like Particle (“eVLP”) Platform Technology
August 5th, 2014
eVLP Platform Technology
June 18th, 2014
Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI
Sign Up Now